Business Description
Founded in 2000 and based in Yavne, Israel, MediWound develops and sells biological treatments that help heal damaged tissue without surgery, operating across the United States, Europe, and other markets. Its main product, NexoBrid, is used in burn centers to remove dead tissue from serious burn wounds. The company is also working on EscharEx, an enzyme-based therapy for chronic and difficult-to-heal wounds, as well as a topical treatment for a common form of skin cancer.
